Products in the field of regenerative medicine
Bioxis Pharmaceuticals has raised €2.5M across 1 funding round from 1 investor, most recently a Early VC round in Sep 2016. Based in Lyon, France; founded 2010; active in Healthtech. Data as of 8 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2016-09-01 | Early VC |
| €2.5M |
| Juvamed |
| View deal → |
